CTOs on the Move

eQHealth Solutions

www.eqhs.com

 
Founded in 1986, eQHealth Solutions is a population health management and technology solutions company that touches millions of lives annually throughout the nation. Our high-tech and high-touch models include innovative technology solutions and care coordination services, and focus on outcomes and optimization of provider and payer networks. eQHealth serves a variety of entities including federal, state and commercial clients.
  • Number of Employees: 250-1000
  • Annual Revenue: $50-100 Million
  • www.eqhs.com
  • 8440 Jefferson Highway Suite 101
    Baton Rouge, LA USA 70809
  • Phone: 800.720.2578

Executives

Name Title Contact Details

Similar Companies

Global Health Strategies

Global Health Strategies (GHS) is an international consulting company that specializes in global health communications, advocacy, research and strategy. We focus on public health issues that impact developing nations and emerging markets. Our clients include leading foundations, industry, NGOs, government agencies, academic institutions and product development. Our work is driven by a passion for improving the health and wellbeing of individuals and communities around the world. We offer the skills, knowledge and goal-driven efficiency to enhance our clients` efforts to address some of the world’s toughest health challenges, including HIV/AIDS, tuberculosis, malaria, polio eradication, sexual and reproductive health and vaccines. GHS has offices in New York, New Delhi, Rio de Janeiro and Beijing, and supports work in countries in Africa, Asia, Europe and the Americas.

NanoGuardian

NanoGuardian is a Skokie, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

PTPN

PTPN is a Calabasas, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Avaxia Biologics

Avaxia is a leader in the growing field of gut-targeted therapeutics — orally administered, minimally absorbed drugs that are designed to act locally in the gastrointestinal tract. Avaxia’s lead clinical candidate, AVX-470, is an oral anti-TNF antibody for inflammatory bowel disease. This transformative product offers potentially improved safety and efficacy over existing anti-TNF therapies by focusing immune suppression only where needed in the diseased gut. Avaxia plans to use its gut-targeted antibody platform to develop therapeutics to address many other serious diseases such as type 2 diabetes, celiac disease, GI acute radiation syndrome and oral mucositis.

CBS Scientific Co Inc

Electrophoresis Equipment including Vertical Electrophoresis(Vertical Gel), Horizontal Electrophoresis(Horizontal Gels), Precast Gels, SDS Page, PCR Workstations, DNA Sequencing, and more. Products for Molecular Separations. CBS Scientific Company.